Secondary prevention after myocardial infarction: Reducing the risk of further cardiovascular events

Coronary Health Care

Volumn 4, Issue 2, 2000, Pages 82-91

  Lockhart, L ^a   McMeeken, K ^a   Mark, J ^a   Cross, S ^a   Tait, G ^a   Isles, C ^a  

^a DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHOLESTEROL; CLOPIDOGREL; DILTIAZEM; ENALAPRIL; HORMONE; HYDRALAZINE; IMDUR RETARD; IRBESARTAN; ISMO RETARD; ISOSORBIDE 5 NITRATE; LACIDIPINE; LANSOPRAZOLE; LISINOPRIL; LOSARTAN; MONIT SR; NICORANDIL; NIFEDIPINE; PERINDOPRIL; PRAVASTATIN; RAMIPRIL; RANITIDINE; SIMVASTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN; VERAPAMIL; WARFARIN;

BLEEDING; BLOOD PRESSURE; BRADYCARDIA; CAR DRIVING; CHOLESTEROL BLOOD LEVEL; COUGHING; DIABETES MELLITUS; DIET; EXERCISE; HEADACHE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HUMAN; HYPERKALEMIA; KIDNEY DISEASE; LETHARGY; MYALGIA; OBESITY; REVIEW; SEXUAL INTERCOURSE; SMOKING; WORK RESUMPTION;

EID: 0033866382     PISSN: 13623265     EISSN: None     Source Type: Journal    
DOI: 10.1054/chec.2000.0066     Document Type: Review

References (63)

1. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
2. Non pharmacological treatment of hypertension
3. Which prophylactic aspirin?
4. Collaborative overview of randomised trials of antiplatelet therapy I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
5. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group
6. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (action on secondary prevention through intervention to reduce events). Principal results
7. Effect of risk factor status on treatment criteria. Implications of hypertension trials
8. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction; diet and reinfarction trial (DART)
9. Antithrombotic agents in coronary artery disease
10. Secondary prevention clinics for coronary heart disease: Randomised trial of effect on health
11. A randomised blinded trial of Clopidogrel versus Aspirin in Patients At Risk of Ischaemic Events (CAPRIE)
12. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
13. Do women with acute myocardial infarction receive the same treatment as men
14. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
15. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish verapamil infarction trial II-DAVIT II)
16. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction
17. Blood pressure, cholesterol and stroke in Eastern Asia
18. Final Consensus Statement 1999 Conference on lipid lowering to prevent vascular events
19. Randomised trial of home based psychosocial nursing intervention for patients recovering from myocardial infarction
20. The Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle aged men with dyslipidaemia
21. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione Trial
22. Cardiovascular events and their reduction with pravastatin in diabetic and glucose intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the CARE Trial
23. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction
24. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial
25. Effects of an ACE inhibitor, Ramipril, on deaths from cardiovascular causes, MI and stroke in high risk patients
26. The management of hypercholesterolaemia following myocardial infarction: Evidence of continued inadequacies in treatment
27. Working party report on cardiac rehabilitation
28. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in post menopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
29. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton Heart Integrated Care Project (SHIP)
30. Psychosocial rehabilitation after myocardial infarction: Multicentre randomised controlled trial
31. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
32. Effect of betablockers in patients with and without diabetes after myocardial infarction
33. An analysis of the effectiveness of interventions intended to help people stop smoking
34. Effects of self help post myocardial infarction rehabilitation on psychological adjustment and use of health services
35. Cardiac rehabilitation in Dumfries and Galloway: A model for rural areas?
36. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
37. Emerging approaches in preventing cardiovascular disease
38. Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease
39. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure
40. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
41. Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,662 men
42. Association of gender and survival in patients with acute myocardial infarction
43. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in congestive heart failure (MERIT-HF)
44. The effect of diltiazem on mortality and reinfarction after myocardial infarction
45. An overview of randomised trials of rehabilitation with exercise after myocardial infarction
46. Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials
47. Cardioprotection by opening of the K(ATP) channel in unstable angina. Results of a randomised study with Nicorandil
48. Smoking and death: The past 40 years and the next 40
49. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
50. Drugs in focus: Nicorandil
51. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
52. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipoprotein cholesterol
53. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
54. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study
55. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
56. Post infarction prognostic stratification
57. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: The GISSI-2 database
58. Joint British Recommendations on Prevention of Coronary Heart Disease in Clinical Practice
59. Beta-blockade during and after myocardial infarction: An overview of the randomised trials